|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
2007-7-10
|
|
pubmed:abstractText |
Middle and low-income countries have scaled up HIV treatment in the past 5 years. To maintain this effort, information regarding the amounts and types of drugs is needed. Shortages or overstock of active pharmaceutical ingredients make the scale-up efforts more difficult and costly. To inform global planning and implementation, we estimate the volume of current and future demand for active pharmaceutical ingredients for first and second-line antiretroviral drugs.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0269-9370
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
21 Suppl 4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
S97-103
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Forecast of demand for antiretroviral drugs in low and middle-income countries: 2007-2008.
|
|
pubmed:affiliation |
Center Evaluation Research and Surveys, National Institute of Public Health (INSP), Cuernavaca, Mexico.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
